SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-025290
Filing Date
2019-04-18
Accepted
2019-04-18 18:47:15
Documents
1
Period of Report
2019-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3162
  Complete submission text file 0001209191-19-025290.txt   4708
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 501 CANAL BLVD. POINT RICHMOND TECH CTR, 501 CANAL BLVD. RICHMOND CA 94804
Business Address
Woolfson Adrian (Reporting) CIK: 0001765497 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-30171 | Film No.: 19756862